• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy
  • Reports
    • Diabetes Technology Innovations Special Report
    • Continuous Glucose Monitoring (CGM) Market Report

mHealth (Mobile Health)

Adherium inks digital health deal with Summatix

August 21, 2019 By Sean Whooley

adherium

Adherium (ASX:ADR) announced a data-based initiative with Summatix to allow clinicians to improve care of patients with asthma and chronic obstructive pulmonary disease across the world. New Zealand-based Adherium and Australia-based Summatix plan to build upon an existing relationship, as the former will gain access to Summatix’s platform to release data from its Hailie sensors […]

Filed Under: Featured, Mergers & Acquisitions, mHealth (Mobile Health), Respiratory Tagged With: Adherium, Summatix

Insulet touts full market launch of mobile apps for Omnipod Dash

August 9, 2019 By Sarah Faulkner

Insulet's Omnipod Dash system

Insulet (NSDQ:PODD) touted the full market launch of the Omnipod Display and Omnipod View apps for people using the company’s Omnipod Dash system. The Display app enables users to display data from their Personal Diabetes Manager device onto their smartphones. The View app gives caregivers and family members the option to remotely monitor Omnipod Dash […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, mHealth (Mobile Health), Pharmaceuticals, Wall Street Beat Tagged With: Insulet

Livongo share prices double after upsized $356m IPO

July 25, 2019 By Brad Perriello

Livongo

Investors added nearly 50% to the share price for Livongo Health (NSDQ:LVGO) today after it raised $355 million with its initial public offering after a last-minute upsizing. The Mountain View, Calif.-based company, which developed a digital health platform to manage chronic diseases, said earlier this week that it planned to float 10.7 million shares at $24 […]

Filed Under: Diabetes, Featured, Funding Roundup, Initial Public Offering (IPO), mHealth (Mobile Health), Wall Street Beat Tagged With: livongohealth

Livongo Health files for $100m IPO

July 1, 2019 By Brad Perriello

Livongo

Livongo Health last week filed for an initial public offering worth $100 million for the digital health platform it developed to treat chronic diseases. The Mountain View, Calif.-based company’s initial focus on diabetes involves a smart, cellular-connected glucose meter, automatically-delivered testing materials, real-time coaching and full-time monitoring. The system personalizes messages based on each glucose […]

Filed Under: Diabetes, Featured, Funding Roundup, Initial Public Offering (IPO), mHealth (Mobile Health), Wall Street Beat Tagged With: livongohealth

Medtronic, Tidepool ink deal for interoperable, automated insulin pump

June 10, 2019 By Sarah Faulkner

Medtronic, Tidepool logo

Medtronic (NYSE:MDT) and nonprofit org Tidepool announced last week that the groups will work together to develop an interoperable, automated insulin delivery system. The medtech giant reported that it plans to build a Bluetooth-enabled MiniMed pump that is compatible with Tidepool’s Loop app, an open-source app for automated insulin delivery. Both companies plan to work […]

Filed Under: Diabetes, Drug-Device Combinations, Featured, mHealth (Mobile Health), Pharmaceuticals Tagged With: Medtronic, tidepool

Diabetes patients could soon replace fingersticks with Senseonics implantable CGM

June 10, 2019 By Chris Newmarker

Senseonics - updated logo

Senseonics (NYSE:SENS)  recently announced that the U.S. FDA has approved using the Eversense implantable continuous glucose monitoring (CGM) system as a replacement for fingersticks. Officials at the Germantown, Md.–based medical device company described the FDA approval for the non-adjunctive indication (dosing claim) as a major milestone. The company will make a new app available in coming months […]

Filed Under: Business/Financial News, Diabetes, Featured, Food & Drug Administration (FDA), mHealth (Mobile Health), Regulatory/Compliance Tagged With: Senseonics

Pops! Diabetes Care launches blood glucose monitoring system

March 12, 2019 By Sarah Faulkner

Pops Diabetes Care logo updated

Pops! Diabetes Care announced today the commercial launch of its blood glucose monitoring system. The Minneapolis-based company’s device won FDA clearance in December last year. The device can be attached directly to the back of a mobile phone and interacts with the user through a coaching app. The Pops! One system also allows users to […]

Filed Under: Business/Financial News, Diabetes, Featured, mHealth (Mobile Health) Tagged With: popsdiabetescare

Senseonics inks CGM data deal with Glooko

March 5, 2019 By Sarah Faulkner

Senseonics - updated logo

Senseonics (NYSE:SENS) said today that data from its Eversense continuous glucose monitoring system can be integrated into Glooko‘s diabetes data management tech. Thanks to the new partnership, Eversense users will be able to view historical glucose trends in Glooko’s mobile and web apps as well as real-time data from the Eversense mobile app, according to Senseonics. […]

Filed Under: Big Data, Diabetes, Drug-Device Combinations, Featured, mHealth (Mobile Health), Wall Street Beat Tagged With: glooko, Senseonics

Abbott touts real-world data for FreeStyle Libre glucose monitor

February 22, 2019 By Sarah Faulkner

Abbott's FreeStyle Libre

Abbott (NYSE:ABT) presented real-world data this week showing that use of its FreeStyle Libre glucose monitoring system reduced prolonged hypoglycemia and helped users achieve better glucose control. At the 12th Advanced Technologies & Treatments for Diabetes meeting in Berlin, the company showcased a real-world evidence data set that included roughly 500,000 FreeStyle Libre system users. Pulling […]

Filed Under: Clinical Trials, Diabetes, Featured, mHealth (Mobile Health), Wall Street Beat Tagged With: abbott

Phillips-Medisize is offering connected health data services: Here’s how

February 20, 2019 By Chris Newmarker

Phillips-Medisize Connected Health Platform

One of the world’s largest medical device contract manufacturers, Phillips-Medisize is making a business play to provide the technological back end for connected drug delivery devices. Phillips-Medisize used to be all about the housings, assembly and packaging that went into finished drug-delivery devices. Electronics was something that other contract manufacturers did. Within a few years, […]

Filed Under: Business/Financial News, Contract Services, Drug-Device Combinations, Featured, mHealth (Mobile Health) Tagged With: Phillips-Medisize

  • « Go to Previous Page
  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Interim pages omitted …
  • Page 8
  • Go to Next Page »

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.
MDO

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
About
Contact us
Listen to our Weekly Podcasts
Advertise

Copyright © 2026 · Arrowfly LLC. All Rights Reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy | Terms & Conditions | RSS